Next Generation News and Research

RSS

Leading driver of antibiotic selection in nosocomial pneumonia in Europe found

Arlington Medical Resources (AMR) and Decision Resources find that the leading driver of antibiotic selection in nosocomial pneumonia in Europe is broad-spectrum activity against gram-positive and gram-negative pathogens.

20 Nov 2009

Parascript releases AccuDetect 3.0 CAD software for film and digital based mammography systems

Parascript, LLC, the image analysis and pattern recognition technology provider, today announced the release of AccuDetect 3.0, the next generation of its computer-aided detection (CAD) software with higher sensitivity and lower false-positive rates when detecting suspicious lesions on mammograms, compared to the previous version of the product.

19 Nov 2009

NanoString Technologies to investigate molecular networks with the Broad Institute of MIT and Harvard

NanoString Technologies, Inc., a privately held life sciences company marketing a molecular barcoding detection system, today announced that it is collaborating with the Broad Institute of MIT and Harvard to investigate molecular networks involved in immune response and other important biological processes.

From NanoString Technologies 19 Nov 2009

Fully integrated human genome sequencing and data processing service launched

Knome, Inc., a recognized pioneer in the personal genomics field, today announced the launch of KnomeDISCOVERY, the first fully integrated human genome sequencing and data processing service for researchers. The new offering meets rapidly emerging demand from biomedical researchers for a one-stop service that bundles affordable, research-tailored access to a broad range of next-generation sequencing platforms with discovery-supportive data management and analysis.

18 Nov 2009

Positive results from REVIVE, a phase 3 pivotal study of avanafil announced

VIVUS, Inc. today announced positive results from REVIVE (TA-301), a phase 3 pivotal study evaluating the safety and efficacy of avanafil, an investigational drug candidate for the treatment of erectile dysfunction (ED), in 646 patients.

18 Nov 2009

Enigma ML, the fully automated Point-of-Care mini-laboratory instrument to be showcased

Enigma Diagnostics Limited, the decentralised point-of-care molecular diagnostics company, announces the showcasing of its fully automated Point-of-Care mini-laboratory instrument, the Enigma ML, at MEDICA 2009 at the Dusseldorf Trade Fair Centrehas in Dusseldorf, Germany in Hall 1, stand E07a between 18-20 November.

18 Nov 2009

ViPS introduces comprehensive software solutions for health payer customers

ViPS, a General Dynamics Information Technology company, today announces its next-generation STARS Solutions suite, an advanced, comprehensive solution to assist health payers -- organizations liable for healthcare coverage for plan members or beneficiaries -- stop healthcare fraud, waste and abuse (FWA).

18 Nov 2009

Medtronic introduces new TSRH 3Dx Spinal System to address multiple pathologies

Medtronic, Inc., today announced the launch of the TSRH® 3Dx™ Spinal System. Designed with procedural efficiency in mind, the TSRH 3Dx Spinal System offers two screws designed to address multiple pathologies.

17 Nov 2009

World Heart, LaunchPoint Technologies sign license agreements

World Heart Corporation (WorldHeart) announced today that it has finalized assignment and exclusive license agreements with LaunchPoint Technologies Inc., (LPT) Goleta, California, and Carnegie Mellon University (CMU), Pittsburgh, Pennsylvania for its next-generation minimally invasive blood pump, the MiVAD. The MiVAD(TM) is designed to provide partial cardiac support between 2-4 liters per minute to less sick heart failure patients than those served by existing full-support Left Ventricular Assist Devices (LVADs).

17 Nov 2009

Helicos Genetic Analysis System to be installed at the Leiden Genome Technology Center

Helicos BioSciences Corporation, today announced the sale of a Helicos® Genetic Analysis System to a collaborative Dutch research group led by the Leiden University Medical Center (LUMC), further including the medical centers of Amsterdam (AMC) Groningen (UMCG) and Rotterdam (Erasmus MC) and funded by a grant from NWO, the Netherlands Organization of Scientific Research.

17 Nov 2009

NIH awards $3 million grant to ASU professors for research on rapid DNA sequencing technology

Arizona State University has been awarded nearly $3 million in federal stimulus funds from the National Institutes of Health. ASU professors Stuart Lindsay and Paul Westerhoff will lead a pair of two-year, innovative projects designed to tackle challenges in the fields of rapid DNA sequencing and the potential health risks of nanotechnology.

17 Nov 2009

Onyx Pharmaceuticals acquires Proteolix

Onyx Pharmaceuticals, Inc. today announced that the company has completed its acquisition of Proteolix, Inc., a privately held biopharmaceutical company focused on discovering and developing novel therapies that target the proteasome for the treatment of hematological malignancies and solid tumors.

16 Nov 2009

RXi Pharmaceuticals announces financial results for the quarter ended September 30, 2009

RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), today reported its financial results for the quarter ended September 30, 2009.

16 Nov 2009

Low-cost, simple interventions could save 2.5 million child lives a year: World Vision

Almost a third of the children under age five who die each year could be saved if governments rebalance health spending to ensure low-cost, simple interventions such as safe water and hygiene, bed nets and basic maternal and newborn care, leading aid agency World Vision said today. Currently, 8.8 million children a year die before age five, most of preventable causes.

16 Nov 2009

Chembio Diagnostics to donate more than 4,500 rapid HIV test kits

Chembio Diagnostics, Inc., a NY-based company that develops, manufactures, licenses and markets proprietary rapid diagnostic tests, is donating more than 4,500 rapid HIV test kits to the AIDS Healthcare Foundation's 2009 Testing Millions Global Campaign, based in Los Angeles, to commemorate World AIDS Day 2009 on December 1st.

16 Nov 2009

M3 USA, Bristol-Myers Squibb to launch next-generation eLearning and eMarketing solution

M3 USA, together with Bristol-Myers Squibb, is launching a pilot program to oncologists using M3’s next-generation eLearning and eMarketing solution. The solution – M3 Messages™ – takes a new approach to developing valuable, long-term, online connections that help doctors stay current on advances in oncology.

13 Nov 2009

CNS Pharmaceuticals' common shares sponsored by 886 AG on the electronic trading platform Xetra

CNS PHARMACEUTICALS AG, (C35.F) a developer and marketer of patented natural nutraceutical products is pleased to announce that the Company’s common shares is sponsored by the German Securities Trading Bank 886 AG Wertpapier Handelsbank on the electronic trading platform Xetra.

13 Nov 2009

New science of happiness doing a profound disservice

The new sciences of happiness are generating lots of advice on how to keep smiling. The results are even being explored by policy wonks. So why does so much of it - work less, say thanks, keep fit - sound so trite? If it were that easy, wouldn't we all be happy by now? The reason is that a central and tricky question is being glossed over: just what is happiness? Moreover, how you try to promote happiness depends entirely on what you take happiness to be - and there's a wealth of choice in that.

13 Nov 2009

SpinalMotion submits Kineflex lumbar artificial disc PMA to FDA

SpinalMotion, developer of the investigational Kineflex® lumbar and Kineflex/C® cervical disc implants for treating patients with degenerative disc disease (DDD), today reported that it has submitted the Pre-Market Approval (PMA) to FDA for the Kineflex lumbar artificial disc

13 Nov 2009

Mithridion reports progress with its potential oral small-molecule drugs for AD and schizophrenia

Mithridion, Inc., a biopharmaceutical company focusing on developing drugs for serious Central Nervous System (CNS) disorders, announced today progress with its pipeline of potential oral small-molecule drugs for Alzheimer's disease (AD) and schizophrenia.

13 Nov 2009

Next Generation News and Research

Leading driver of antibiotic selection in nosocomial pneumonia in Europe found

Parascript releases AccuDetect 3.0 CAD software for film and digital based mammography systems

NanoString Technologies to investigate molecular networks with the Broad Institute of MIT and Harvard

Fully integrated human genome sequencing and data processing service launched

Positive results from REVIVE, a phase 3 pivotal study of avanafil announced

Enigma ML, the fully automated Point-of-Care mini-laboratory instrument to be showcased

ViPS introduces comprehensive software solutions for health payer customers

Medtronic introduces new TSRH 3Dx Spinal System to address multiple pathologies

World Heart, LaunchPoint Technologies sign license agreements

Helicos Genetic Analysis System to be installed at the Leiden Genome Technology Center

NIH awards $3 million grant to ASU professors for research on rapid DNA sequencing technology

Onyx Pharmaceuticals acquires Proteolix

RXi Pharmaceuticals announces financial results for the quarter ended September 30, 2009

Low-cost, simple interventions could save 2.5 million child lives a year: World Vision

Chembio Diagnostics to donate more than 4,500 rapid HIV test kits

M3 USA, Bristol-Myers Squibb to launch next-generation eLearning and eMarketing solution

CNS Pharmaceuticals' common shares sponsored by 886 AG on the electronic trading platform Xetra

New science of happiness doing a profound disservice

SpinalMotion submits Kineflex lumbar artificial disc PMA to FDA

Mithridion reports progress with its potential oral small-molecule drugs for AD and schizophrenia

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News